| Diagnostics | Battery-operated molecular diagnostic devices, reagents, and chips for infectious and non-communicable diseases. | Proprietary PCR technology, ease of use in remote settings, strong institutional relationships. | Public health programs, labs, hospitals (B2B). | Consumables and reagents for Truenat platform. | 1306 | 90 | Device sales, consumables, and testing services. | Direct sales and recurring consumables revenue. | Increased demand for rapid diagnostics, government health initiatives, innovation in POC testing. | Truenat PCR platform |
| Medical Imaging & Digital Pathology | Radiology imaging devices and digital pathology scanners targeting diagnostic centers and hospitals. | Strategic acquisitions providing technology and market access in advanced diagnostic segments. | Hospitals, diagnostic centers (B2B). | High-end imaging equipment and pathology scanners. | 139 | 10 | Sales of equipment and related services. | Direct sales with service contracts. | Acquisitions expanding product portfolio and adoption of digital pathology solutions. | Prognosys radiology equipment, OptraScan digital pathology scanners |
